Table 6.
Factors associated with demand for COVID-19 vaccination in regression analysis
Univariate analysis | Multivariate analysis | |||
OR (95% CI) | P value | aOR (95% CI) | P value | |
Study site Geneva | Reference | Reference | ||
Baltimore | 2.24 (1.51 to 3.33) | <0.001 | 0.97 (0.56 to 1.68) | 0.920 |
Milan | 1.70 (1.14 to 2.54) | 0.009 | 1.18 (0.66 to 2.09) | 0.578 |
Paris | 0.26 (0.15 to 0.47) | <0.001 | 0.15 (0.06 to 0.38) | <0.001 |
Gender female | 1.43 (1.07 to 1.92) | 0.016 | 1.23 (0.80 to 1.88) | 0.344 |
Age (per additional year) | 1.04 (1.02 to 1.05) | <0.001 | 1.02 (1.00 to 1.04) | 0.019 |
Region of origin Europe | Reference | Reference | ||
Africa | 0.75 (0.38 to 1.46) | 0.396 | 2.73 (0.93 to 8.02) | 0.069 |
Americas | 1.62 (0.94 to 2.80) | 0.085 | 0.85 (0.36 to 1.96) | 0.695 |
Eastern Mediterranean | 0.93 (0.45 to 1.93) | 0.852 | 1.93 (0.63 to 5.86) | 0.247 |
South-East Asia | 0.38 (0.15 to 1.01) | 0.052 | 0.45 (0.12 to 1.65) | 0.231 |
Western Pacific | 0.90 (0.46 to 1.78) | 0.769 | 0.69 (0.26 to 1.87) | 0.467 |
≥1 comorbidity | 1.91 (1.40 to 2.61) | <0.001 | 1.77 (1.10 to 2.84) | 0.018 |
High self-perceived risk of severe COVID-19 | 1.46 (1.06 to 2.01) | 0.019 | 1.26 (0.81 to 1.96) | 0.315 |
COVID-19 infection (self) | 1.37 (0.92 to 2.05) | 0.124 | 1.23 (0.66 to 2.27) | 0.514 |
COVID-19 infection (household) | 1.23 (0.84 to 1.79) | 0.292 | 0.84 (0.48 to 1.49) | 0.557 |
Positive views on vaccination (general) | 32.5 (14.2 to 74.4) | <0.001 | 12.9 (5.17 to 32.22) | <0.001 |
Positive views on vaccination (COVID-19) | 16.70 (11.2 to 24.8) | <0.001 | 9.70 (6.08 to 15.47) | <0.001 |
Information through traditional media (TV, radio, web) | 2.25 (1.53 to 3.29) | <0.001 | 1.28 (0.75 to 2.18) | 0.360 |
Information through social media | 0.47 (0.35 to 0.62) | <0.001 | 0.84 (0.55 to 1.28) | 0.410 |
Information through community network | 0.47 (0.33 to 0.65) | <0.001 | 0.61 (0.38 to 1.00) | 0.049 |
Information through other source | 0.30 (0.12 to 0.73) | 0.008 | 0.44 (0.13 to 1.43) | 0.170 |
Self-perceived accessibility to COVID-19 vaccination | 1.19 (0.78 to 1.81) | 0.421 | 1.08 (0.61 to 1.92) | 0.799 |
aOR, adjusted OR.